B-cell-specific expression of the immunoglobulin kappa light-chain (Igc) gene is in part accomplished by negative regulatory influences. Here we describe a new negatively acting element (termed KNE) immediately upstream of the NF-cB-binding site in the Igc intronic enhancer. The 27-bp KNE sequence is conserved in the corresponding positions in the rabbit and human IgK genes, and the human KNE homolog was shown to have a similar negative regulatory activity. Data base searches using the mouse KNE sequence revealed a striking homology to murine Bi repetitive sequences. A sequence homologous to KNE and B1 was also noted in a previously identified silencer element in the murine T-cell receptor a locus. The homologous T-cell receptor a locus sequence, but notably not a corresponding 27-bp Bi consensus sequence, showed a negative regulatory potential similar to that of KNE. The negative effect of KNE by itself was not cell type specific but became so when paired with its 5'-flanking sequence in the Igc enhancer. A short (30-bp) fragment upstream of KNE (termed KBS) was found to be necessary and sufficient for abolishing the negative effect of KNE in B cells. Point mutations in a T-rich motif within the cBS sequence allowed the transcriptional repression by KNE to be evident in B cells as well as other cells. As suggested by this cell-independent negative activity, proteins binding to the mouse and human KNE sequences were identified in all cell types tested.
The regulation of the immunoglobulin K light-chain (IgK) gene during B-cell development involves the IgK promoter and two distinct enhancer elements (for a review, see reference 11) . The better characterized of the two IgK enhancers resides in the intron between the J and C regions, whereas the more recently identified 3' enhancer is located several kilobases downstream of the IgK constant region. Both of these enhancers contain multiple sites for positive and negative regulation.
Some of the B-cell-specific activity of the IgK intronic enhancer can be attributed to the cell type specificity of the key positive regulator NF-KB (10) , which becomes constitutively activated in the nuclei of maturing B cells (2) . Although NF-KB can be activated from its inactive cytosolic form in most other cell types, this activation does not lead to an increased IgK intronic enhancer activity in non-B cells, such as T cells (17) . Some of this cell type-specific negative regulation has been mapped to a 200-bp fragment upstream of the NF-KB-binding site (16) . Removal of these sequences results in the inducibility of the IgK enhancer by NF-KB site activators in non-B cells.
Here we show that another component of negative regulation at this locus can be ascribed to a short sequence immediately 5' of the KB site in the IgK intronic enhancer. The activity of this element is not cell specific but becomes so when paired with a neighboring short sequence. The minimal negative element, but none of its flanking sequences in the IgK intronic enhancer, is closely related to the murine Bi repeat elements. Our experiments with a similar sequence from the T-cell receptor a locus (TCRa) enhancer indicate that Bl-like sequences in other genetic contexts may be generally important as negative regulatory elements. Finally, we identify specific KNE-binding factors in nuclear * Corresponding author.
extracts from several cells and show that this binding activity correlates with the transcriptional repression by KNE.
MATERUILS AND METHODS
Plasmid constructs. The pfLUC plasmid was constructed by cloning the mouse fos promoter sequences (-56 to +109; from plasmid A56-fos-CAT; 6) to plasmid pBL-KS, made by inserting a new cloning site into the pBL vector (kindly provided by David Cobrinik, Whitehead Institute, Cambridge, Mass.) with the Photinus pyralis luciferase coding sequence in a pBluescript-based plasmid.
The NF-KB-driven plasmid pBIIX was constructed by inserting a synthetic fragment with two copies of the sequence ACA GAG GGG ACT TTC CGA GAG separated by four nucleotides (ATCT) in front of mouse fos promoter in plasmid pfLUC. The IgK fragments with different 5' ends were polymerase chain reaction (PCR) amplified from an IgK J-C region-containing plasmid and cloned into a SacI site immediately upstream of the first KB-binding site in pBIIX. Thus, all the resulting inserts had identical 3' ends with IgK sequence extending to position 3934 and had mutated residues at positions 3927 and 3929 (C to G and T to G, respectively) to create the Sacl site (see Fig. 3A for sequence in this region). Since the functionally critical region of the IgK negative element was localized immediately 5' of the introduced SacI site, we also constructed a plasmid in which the IgK insert shared its 5' end with the 192-bp fragment but had a perfect wild-type sequence extending all the way to (and including Gel mobility shift assays. Nuclear extracts were prepared as previously described (3) . The oligonucleotide probes were synthesized with an Applied Biosystems 392 DNA/RNA Synthesizer and their nucleotide sequences were as follows: mouse KNE, 5'-ACC TCT GTC ACC CAA GAG TTG GGA GCT CAG CTC CCA ACT CTl GGG TGA CAG AGG T-3'; mutant mouse cNE, 5'-ACC TCT GTTh_TC CAA GAG TACLIGA GCT CAG CTC AGT ACT CTl GGA CAA CAG AGG T-3' (mutations in the sense-strand region of the oligonucleotide underlined); and human KNE, 5'-TGC TCT CCC ACC CAA CGG GTG GGA GCT CAG CTC CCA CCC GTT GGG TGG GAG AGC A-3'. The oligonucleotides were purified from an acrylamide gel, 100 ng of each oligonucleotide was end labeled, extracted twice with phenol-chloroform, diluted to 2 ml with TE (Tris-EDTA), boiled for 3 min, and allowed to sit at room temperature to allow self-annealing. The labeled probes were concentrated and separated from unincorporated radioactivity by three rounds of microconcentration using Centricon-10 columns (Amicon). Nuclear extract (10 ,ug) Fig. 1A for Jurkat cells). In contrast, in mature B cells (S194 or P3X), the 192-bp IgK fragment had a marginal or no effect on NF-KB-driven transcription. Also, no negative effect on PMA-stimulated luciferase expression by the 192-bp IgK fragment was observed in any pre-B-cell lines tested (22D6, PD31, 70Z/3, and NFS-5); instead, slightly higher luciferase activities were observed than in pBIIX-transfected cells (22D6 cells [Fig. 1A]) .
Analysis of the effect of successive 5' deletions of this 192-bp fragment indicated that its negative effect could be restricted to a 27-bp sequence (referred to as KNE) immediately upstream of the NF-KB-binding site in the IgK intronic enhancer ( Fig. 1A ; see also Fig. 3A ). When an even shorter 17-bp fragment was tested, the negative effect was weaker, but this construct still showed consistently -50% lower transcriptional activity than the pBIIX construct. A multimer consisting of three copies of this 17-bp sequence had a negative effect slightly stronger than any of the monomeric IgK fragments (construct 3 x 17 in Fig. 1A ).
We further examined the KNE sequence requirements by introducing mutations into the 192-bp IgK fragment within the 17-bp region indicated above (Fig. 1B) sequence, confirming the functional importance of this region, as indicated by our deletion studies. The negative effect of the 192-bp fragment was also affected by deletion of the three nucleotides, GAG, in the middle of this region (192D), but not by changing these residues to ATA (192M), suggesting that not every residue within this 17-bp region is critical as long as a correct nucleotide spacing is conserved. Some residual negative effect remained in all of these 192-bp fragments, as was the case when the whole 17-bp region was changed to an unrelated sequence (not shown), indicating some contribution of the more 5' sequences, presumably the CT-rich region present in the 27-bp fragment but not in the 17-bp fragment shown in Fig. 1A because it has properties that suggest it has general significance.
To study whether the negative effect of the KNE was restricted to NF-KB, we precisely replaced the KB sites in the pBIIX construct and its derivative carrying the 192-bp IgK fragment (Fig. 1A) by two copies of the cyclic AMP responsive element consensus sequence (TGACGTCA [19] ) and measured the forskolin-stimulated and unstimulated luciferase expression of these constructs in Jurkat cells. In both cases, an approximately threefold-lower luciferase activity was produced by the 192-bp IgK fragment-containing vector (not shown). Thus, the negative activity of KNE is not restricted to NF-KB, but it can downregulate transcription activated via other binding sites.
A sequence homologous to the murine KNE is also present adjacent to the KB site in the human IgK intronic enhancer ( Fig. 2A) , suggesting that it might have a similar negative regulatory role. We tested this directly by introducing the human 27-bp KNE sequence into the pBIIX reporter construct and found that this element could indeed interfere with NF-KB-driven transcription and have a negative effect corresponding to that of the mouse KNE (Fig. 2C) . The conservation of KNE between the mouse, human, and rabbit sequences highlights the significance of this element and points to the importance of the specific residues indicated by our mutagenesis studies.
KNE is homologous to the Bi repeat element. When we screened the GenBank data base using the 27-bp murine KNE sequence, a large number of almost perfect alignments was found. This turned out to be due to the homology of KNE to the mouse Bi short repetitive sequences and their primate Alu counterparts (Fig. 2B) . This homology was shared only by the KNE region and did not extend to its flanking sequences in the IgK enhancer.
Interestingly, we noted that a Bl-homologous sequence corresponding to KNE is also present in a previously characterized silencer element, TCRSIL2 (24) , in the mouse T-cell receptor a gene locus (Fig. 2B) . We tested this 27-bp TCRot fragment in our KB-driven reporter gene system and found it to have a negative transcriptional effect similar to that of KNE (Fig. 2C) . The plasmid constructs used in these experiments had the TCRa sequence inserted in an orientation opposite to that of KNE (which was in the sense orientation). Both TCRa and IgK 27-bp fragments were, however, able to repress transcription in either orientation.
We then tested a 27-bp B1 consensus fragment (cB1 in Fig.  2B (Fig. 1A) , we found that disruption of the KNE sequence from its upstream flanking region resulted in an activation of its negative potential in B cells (Fig. 1A) . In contrast to the 192-bp IgK fragment, the 27-bp KNE fragment could repress transcription in all cell types tested, including B cells. The presence of only 30 bp of IgK sequences upstream of the KNE, however, was sufficient to restore the cell type specificity of the KNE, since no negative effect was observed for the 57-bp fragment when tested in S194 cells (Fig. 1A) . Therefore, this 30-bp region is a critical determinant of the cell type specificity of KNE. The nucleotide sequence of this 30-bp fragment (referred to as KBS for IgK B-cell specificity) is shown in Fig. 3A . The KBS sequence contains two copies of the T-rich motif GTTIT separated by a C residue. Disruption of this region of the iBS element in the reporter construct with a 96-bp IgK fragment by a TTCGTT-to-GCGCGC mutation activated the negative potential of this fragment in S194 cells, rendering it as potent a negative element in B cells as in non-B cells (compare constructs 96 and 96B in Fig. 1A) .
To test whether the KBS-mediated B-cell-specific alleviation of the negative regulation by KNE could be due to an independent positive transcriptional effect by KBS, we introduced two copies of the KBS sequence in front of the minimal fos promoter in the pfLUC luciferase construct. Luciferase expression of the resulting plasmid pKBS was A. then compared with that of pfLUC in B cells and non-B cells. No significant transcriptional stimulation was observed in either cell type, suggesting that the KBS element by itself has no transcriptional activation potential. However, when the two copies of the KBS sequence were cloned 5' of the NF-KB binding sites in plasmid pBIIX (resulting in plasmid pKBS-KB), a marked enhancement in transcription was observed in B cells (Fig. 3B) . The strong transcriptional activation by two murine IgK KB sites in S194 cells was further increased two-to threefold by the additional tandem KBS element. In contrast, no such potentiation of the NF-KB-activated transcription by KBS was seen in PMA-stimulated Jurkat cells; instead, less luciferase was expressed in these cells by the pcBS-KB plasmid than by pBIIX (Fig. 3B) . A sequence homologous to the mouse KBS element is also present adjacent to the KNE element in the human kappa enhancer. A similar B-cell-specific enhancement of transcriptional activation via the IgK KB site was also observed with the human KBS sequence (data not shown).
These data suggest a role for the KBS element as a cell type-specific modulator of transcriptional activation via the NF-KB-binding site within the IgK intronic enhancer. Thus, combined influences by these three closely positioned binding sites (KBS, KNE, and KB) appears to create a composite enhancer element whose activity is regulated by NF-KB but is mainly restricted to the B-cell lineage.
Sequence-specific nuclear factor binding to KNE correlates with its negative regulatory potential. To characterize factors mediating the negative transcriptional effect of the KNE, we prepared nuclear extracts from various B-cell and non-B-cell lines and tested them for specific binding to the KNE sequence in gel retardation assays. In agreement with the ubiquitous activity of KNE, a specific complex binding to the mouse KNE probe was detected in mouse (S194 and 22D6) and human (Jurkat and HeLa) cell lines regardless of their lineage of differentiation (complex A in the left panel in Fig.  4 ; also data not shown). The specificity of DNA binding by complex A was strongly suggested by the experiments utilizing different unlabeled competitor binding sites and a mutated version of the KNE probe (discussed below). The binding of complex A was not very strong; this binding became evident only when glycerol was added to the mobility shift gels to stabilize the binding and increased when electrophoresis was carried out at 4°C. Under these conditions, an additional slower migrating specific complex was also observed in HeLa cells (A' in Fig. 4, left panel) ) and B-cell lineages (22D6; v-Abl-transformed mouse pre-B-cell line) were tested for factors that could specifically bind to mouse and human (hu) KNE probes, as well as a mutant mouse and human KNE probes (*) with changes in nucleotide residues critical for transcriptional repression by the murine KNE sequence. In some lanes, a 100-fold excess of the indicated unlabeled competitor was also included in the binding reaction mixture. In lanes labeled -, no specific competitor was used. The details of the assay and the sequences of the oligonucleotide probes used are specified in the Materials and Methods. Complexes specifically interacting with the mouse (A and A') and human (B) KNE sequences are indicated by arrows.
due to a cell-type-restricted KNE-binding factor but more likely reflects a higher quality of the nuclear extracts prepared from HeLa cells. Although there is no direct evidence that the constituents of complexes A and A' are related, we will refer to both of them as mBl-NF (for murine Bl-binding nuclear factor).
To test whether binding of mBl-NF to the 27-bp KNE element correlated with its transcriptional repression potential, we prepared a mutant probe (mouse KNE* [lanes 1 and 11 in Fig. 4] ) in which residues CAC and TGG were changed to TGT and ACT, respectively (for details, see Materials and Methods). On the basis of our mutagenesis studies (Fig. 1B) , these changes should abolish transcriptional repression by mouse KNE and, therefore, presumably disrupt binding of any functionally relevant negative factors. No mBl-NF binding was observed with this mutant version of the KNE sequence, indicated by the complete absence of complexes A and A' in Fig. 4 (compare lanes 1 and 2 and lanes 11 and  12) . Identical arrays of complexes binding nonspecifically to both the mutant and wild-type probe highlighted the specificity of the loss of mB1-NF interaction with the mutant KNE probe. In agreement with these results, a 100-fold excess of the mutant KNE fragment was unable to abolish B1-NF binding to the wild-type KNE probe. In contrast, under the same conditions, a 100-fold excess of the wild-type KNE competitor completely abolished the B1-NF complex (Fig.  4) . These data confirm that the mBl-NF complex binds specifically to the mouse KNE sequence and show that this interaction is dependent on the nucleotide residues critical for the negative regulatory potential of KNE.
These results prompted us to use other fragments homologous to KNE and Bi and previously tested for their transcriptional regulatory potential as specific competitors for B1-NF binding to the mouse KNE probe. It is striking that the KNE-like fragment from the TCRot silencer, which had a negative regulatory potential comparable to that of KNE, was also able to efficiently abolish mBl-NF binding to the KNE probe (Fig. 4, lanes 5 and 15) . In contrast, despite its close sequence similarity, the corresponding 27-bp mouse Bi repeat consensus fragment failed to abolish mBl-NF binding (lanes 6 and 16), which correlated with its lack of negative regulatory potential in reporter gene assays (Fig.  2C) . These results substantiate the significance of the mBl-NF as a mediator of the negative regulation by KNE and suggest a role for it in negative regulation by a subset of other Bl-homologous sequences dispersed in the mouse genome, such as the Bi homology region in the TCRa silencer.
The negatively acting human KNE homolog, however, did not abolish binding of mBl-NF to the mouse KNE probe in nuclear extracts either from mouse or human cell lines (Fig.  4, lanes 7 and 17) . In order to understand this finding, we prepared a similar mobility shift probe corresponding to the human KNE sequence. A single specific binding complex was observed by using the human KNE probe in mouse and human cell lines (complex B in Fig. 4 (Fig. 4, right  panel) . Also, 100-fold excess of unlabeled human KNE* fragment failed to abolish binding of complex B to the human KNE probe. Thus, distinct factors, present in mouse and human cells, appear to be involved in complexes with the mouse and human KNE sequences in vitro. These factors have similar but distinct specificities in their binding to DNA. The same nucleotide residues that were found to be critical for the negative function of mouse KNE were also necessary for binding of both mBl-NF and hBl-NF, yet the mouse and human KNE sequences did not cross-compete for their binding to these factors. Thus, mBl-NF and hBl-NF could be distinct but related members of a family of nuclear proteins. Studies examining molecular characterization of the constituents of the mB1-NF and hB1-NF complexes will be needed to clarify their role and mode of action in transcriptional repression.
DISCUSSION
In this study, we have identified a previously unrecognized short negative element (KNE) close to the NF-KBbinding site in the IgK intronic enhancer. Computer analysis of the KNE sequence revealed a striking homology to the murine Bi repetitive element of the short interspersed repetitive element superfamily (see below). Nuclear factors specifically binding to KNE were identified and termed B1-NF. Functional significance of the B1-NF complex was supported by mutagenesis and binding site competition studies which established a strong correlation between B1-NF binding to KNE in vitro and transcriptional repression in vivo. Further characterization of B1-NF will be necessary to uncover the molecular mechanisms involved in the transcriptional repression by KNE and other similar elements.
The cell type specificity of KNE was found to be determined by a short element, termed KBS, immediately upstream of KNE in the IgK enhancer. Disruption of the KBS sequence allowed transcriptional repression by KNE to be evident in B cells. When analyzed separately from KNE, the KBS sequence was able to cause a B-cell-specific enhancement of transcriptional stimulation via adjacent NF-KBbinding sites but by itself could not mediate transcriptional activation. In these properties, KBS is reminiscent of the sequence that binds the high-mobility-group protein-related lymphoid enhancer factor 1, a protein that bends DNA and potentiates the activity of other factors while being inactive on its own (5).
Nelms and collaborators (14, 15) have previously studied nuclear factors binding to the human and mouse IgK enhancers, using probes including the KBS sequences described here. They concluded that the human sequence is a functional octamer-binding site, whereas the corresponding mouse sequence instead binds another nuclear factor referred to as KBF-A. Our gel shift experiments using mouse and human KBS probes (20a) Alu-like element and then suffered a deletion some time before these species diverged in evolution.
The idea that Bi elements may have a widespread role in the negative control of gene expression was strongly supported by the finding that a sequence homologous to KNE and Bi is also shared by another previously identified negative element, namely, TCRSIL2, which is involved in down-regulation of TCR(x expression in cells other than oa3-lineage T cells (24) . The Bl-like sequence in TCRSIL2 is a more typical Bi element than KNE is, which suggests a more recent evolutionary origin. Therefore, the ability of the 27-bp KNE-or Bl-like TCRSIL2 fragment to negatively regulate reporter gene transcription and to abolish binding of mBl-NF to the KNE sequence demonstrates that the Bi homology of the KNE sequence is functionally relevant. Another 27-bp fragment, corresponding to the most prevalent (consensus) sequence in this region of the Bi elements, however, did not show any negative regulatory activity in our test system and it did not compete with the KNE probe for mBl-NF binding. Thus, it appears that only certain variants of the Bl-like sequences may acquire a negative regulatory function.
A role for some other highly repeated sequences in the negative control of transcription has been suggested by previous studies. The silencer element in the rat insulin 1 locus was identified as a member of a rat long interspersed repetitive sequence family (9) . One of the three identified chicken lysozyme silencer elements was found to consist of sequences homologous to the chicken middle repetitive sequence element CR1 (1) . Also, although the Alu sequences have not been indicated in negative regulation of any specific genes, their potential for transcriptional repression has been suggested (20, 21) .
Bi sequences, as well as many of the other highly repeated genomic sequences, are thought to represent retrotransposons, DNA elements which can be copied into new positions in the genome through RNA intermediates. Evolutionary characterization, as well as rare studies in real time (4) , has confirmed that some of repeated sequences, including the Alu elements (13, 22) , continue to retrotranspose. The notion that these sequences, after perhaps a small number of mutations, can play a physiological role has been an attractive one for many years, but has received little support (recently reviewed by Howard and Sakamoto [8] ). Involvement of a mobile DNA element in transcriptional regulation would allow alterations in gene expression to occur with great flexibility, ease, and speed over evolutionary time.
It is tempting to speculate that in addition to IgK and TCRao enhancers, Bl-like sequences could be widely used as versatile building blocks that confer a negative transcriptional effect onto a variety of different cell type-and differentiation-specific enhancers. A large number of the murine and primate genes so far sequenced and characterized contain Bi-and Alu-like sequences in positions which could imply regulatory significance (20a) . Further studies addressing the detailed sequence and spatial requirements functionally critical for Bl-like negative elements should help predicting which ones are likely to be involved in the control of gene expression.
